BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38366813)

  • 1. Assessment of SOX10 expression in 437 canine neoplasms of different embryologic origins.
    Nelissen S; Miller AD
    Vet Pathol; 2024 Feb; ():3009858241231562. PubMed ID: 38366813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
    Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
    Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Expression of
    Tsoi MF; Thaiwong T; Smedley RC; Noland E; Kiupel M
    Front Vet Sci; 2021; 8():701457. PubMed ID: 34422947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
    Karamchandani JR; Nielsen TO; van de Rijn M; West RB
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):445-50. PubMed ID: 22495377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.
    Ohtomo R; Mori T; Shibata S; Tsuta K; Maeshima AM; Akazawa C; Watabe Y; Honda K; Yamada T; Yoshimoto S; Asai M; Okano H; Kanai Y; Tsuda H
    Mod Pathol; 2013 Aug; 26(8):1041-50. PubMed ID: 23558573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX10 expression in mammary invasive ductal carcinomas and benign breast tissue.
    Chiu K; Ionescu DN; Hayes M
    Virchows Arch; 2019 Jun; 474(6):667-672. PubMed ID: 30903273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
    Hsieh MS; Lee YH; Chang YL
    Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox10: a pan-schwannian and melanocytic marker.
    Nonaka D; Chiriboga L; Rubin BP
    Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX2 Expression in Canine Neoplasia.
    Miranda IC; Miller AD
    Vet Pathol; 2021 Sep; 58(5):964-970. PubMed ID: 32975490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
    Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX10/keratin dual-color immunohistochemistry: An effective first-line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens.
    Mito JK; Conner JR; Hornick JL; Cibas ES; Qian X
    Cancer Cytopathol; 2018 Mar; 126(3):179-189. PubMed ID: 29385322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment.
    Szumera-Ciećkiewicz A; Bosisio F; Teterycz P; Antoranz A; Delogu F; Koljenović S; van de Wiel BA; Blokx W; van Kempen LC; Rutkowski P; Christopher van Akkooi A; Cook M; Massi D;
    Eur J Cancer; 2020 Sep; 137():175-182. PubMed ID: 32781392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues.
    Ginn PE
    Vet Pathol; 1996 Sep; 33(5):533-41. PubMed ID: 8885180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population.
    Liu HG; Kong MX; Yao Q; Wang SY; Shibata R; Yee H; Martiniuk F; Wang BY
    Head Neck Pathol; 2012 Dec; 6(4):401-8. PubMed ID: 22736149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
    Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
    J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors.
    Aphivatanasiri C; Li J; Chan R; Jamidi SK; Tsang JY; Poon IK; Shao Y; Tong J; To KF; Chan SK; Tam F; Cheung SY; Shea KH; Tse GM
    Breast Cancer Res Treat; 2020 Nov; 184(1):11-21. PubMed ID: 32737715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Sry-Related HMG-Box Gene 10 (SOX10) as a marker of melanoma in effusion cytology.
    Dermawan JKT; Underwood D; Policarpio-Nicolas ML
    Diagn Cytopathol; 2019 Jul; 47(7):653-658. PubMed ID: 30794352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of SOX10 Expression in Human Pathology.
    Bahmad HF; Thiravialingam A; Sriganeshan K; Gonzalez J; Alvarez V; Ocejo S; Abreu AR; Avellan R; Arzola AH; Hachem S; Poppiti R
    Curr Issues Mol Biol; 2023 Dec; 45(12):10131-10158. PubMed ID: 38132479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
    Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
    Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.